Boehringer Ingelheim initiates clinical evaluation of novel compound for chronic kidney disease

Boehringer Ingelheim initiates clinical evaluation of novel compound for chronic kidney disease
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news